HealthQuill joint pain
Novartis AG’s end-stage trial of a drug to treat the inflammation of arteries, which affects people aged over 50 years, has failed to meet its primary goal of being symptom-free after a year of therapy.
Drugs Health Pharma

Novartis’ drug to treat inflammation of arteries fails in end-stage trials

HQ Team July 3, 2025: Novartis AG’s end-stage trial of a drug to treat the inflammation of arteries, which affects people aged over.

Read More
Researchers at the University of Central Florida have engineered a human tissue that draws mosquitoes to bite and feed on, and hope the platform can help study the pattern of how the pathogens the insects carry impact and infect human cells and tissues.
Climate Health Medical

Brazil reels under dengue, public health emergency declared

HQ Team February 9, 2024: As millions descend in Rio De Janeiro in Brazil for the world-famous Carnival starting today, the government has.

Read More
Health Medical Pharma

Atom Bioscience promotes gout awareness with new campaign

Gout affects about 1% of the population and is more common in men, particularly those aged 30 to 60, and in women who.

Read More
Health Medical

New injectable cell therapy shows promise in treating osteoarthritis

Scientists develop cell therapy that when injected in the inflamed joints reduces pain and repairs cartilage

Read More